{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:59:37Z","timestamp":1792979977606,"version":"4.5.0"},"reference-count":319,"publisher":"Portland Press Ltd.","issue":"18","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"abstract":"<jats:p>The global prevalence of obesity has exerted a profound influence on human health. It has contributed to numerous obesity-related comorbidities, including metabolic dysfunction-associated steatotic liver disease (MASLD) and insulin-resistant diabetes. MASLD is diagnosed when there is substantial fat accumulation concomitant with five additional diagnostic criteria. If untreated, MASLD may progress to liver fibrosis and cirrhosis, conditions that can be life-threatening in the final stages. Nonetheless, the development and progression of MASLD are complex, and its underlying mechanisms remain incompletely elucidated. Typically, during fasting, adipose tissue releases fatty acids, which the liver subsequently uptakes for gluconeogenesis. However, this process, along with many others, is impaired in the liver and adipose tissue of individuals with MASLD. This review provides comprehensive details on the mechanisms underlying adiposity and insulin resistance associated with MASLD. We discuss the canonical pathways that promote lipogenesis and insulin sensitivity in the liver and adipose tissues, including bile acids, bilirubin, fatty acids, inflammation, de novo lipogenesis, oxidative stress, peroxisome proliferator-activated receptors (PPARs), fibroblast growth factor 21 (FGF21), glucagon-like peptide 1 (GLP1), and metabolism of fructose. The scope of the review is expanded to encompass biological responses to fasting and feeding, as well as their effects on fat accumulation and insulin sensitivity in these tissues. Additionally, the review elaborates on critical molecular mechanisms regulating MASLD progression, including hepatic insulin clearance, insulin degradation, bilirubin metabolism, nerve innervation, and the roles of cytokines and adipokines. Overall, this review examines the mechanisms driving MASLD and explores potential novel therapeutic strategies for its management.<\/jats:p>","DOI":"10.1042\/cs20257571","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T12:41:44Z","timestamp":1758717704000},"page":"1015-1046","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The physiology of MASLD: molecular pathways between liver and adipose tissues"],"prefix":"10.1042","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5258-8318","authenticated-orcid":false,"given":"Wang-Hsin","family":"Lee","sequence":"first","affiliation":[{"name":"1Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-7469","authenticated-orcid":false,"given":"Zachary A.","family":"Kipp","sequence":"additional","affiliation":[{"name":"1Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4157-2481","authenticated-orcid":false,"given":"Evelyn A.","family":"Bates","sequence":"additional","affiliation":[{"name":"1Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7365-7172","authenticated-orcid":false,"given":"Sally N.","family":"Pauss","sequence":"additional","affiliation":[{"name":"1Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-7708","authenticated-orcid":false,"given":"Genesee J.","family":"Martinez","sequence":"additional","affiliation":[{"name":"1Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-1529","authenticated-orcid":false,"suffix":"Jr.","given":"Terry D.","family":"Hinds","sequence":"additional","affiliation":[{"name":"1Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, U.S.A"},{"name":"2Barnstable Brown Diabetes Center, University of Kentucky College of Medicine, Lexington, KY, U.S.A"},{"name":"3Markey Cancer Center, University of Kentucky, Lexington, KY, U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"2025092408413438700_CS-2025-7571C1","doi-asserted-by":"crossref","first-page":"155607","DOI":"10.1016\/j.metabol.2023.155607","article-title":"Hepatic insulin receptor: new views on the mechanisms of liver disease","volume":"145","author":"Lee","year":"2023","journal-title":"Metab. Clin. Exp"},{"key":"2025092408413438700_CS-2025-7571C2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"2025092408413438700_CS-2025-7571C3","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021","volume":"14","author":"Yang","year":"2024","journal-title":"Sci. Rep."},{"key":"2025092408413438700_CS-2025-7571C4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci. (Lond)"},{"key":"2025092408413438700_CS-2025-7571C5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-Art Review","volume":"32","author":"Chan","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"2025092408413438700_CS-2025-7571C6","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.pharmr.2024.100018","article-title":"Pharmacological treatment for metabolic dysfunction-associated steatotic liver disease and related disorders: Current and emerging therapeutic options","volume":"77","author":"Zhang","year":"2025","journal-title":"Pharmacol. Rev"},{"key":"2025092408413438700_CS-2025-7571C7","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-020-00558-9","article-title":"Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon","volume":"20","author":"Fahed","year":"2020","journal-title":"BMC Endocr. Disord."},{"key":"2025092408413438700_CS-2025-7571C8","doi-asserted-by":"crossref","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","article-title":"Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride\/glucose index","volume":"16","author":"Tahapary","year":"2022","journal-title":"Diabetes Metab. Syndr"},{"key":"2025092408413438700_CS-2025-7571C9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diabres.2010.04.013","article-title":"Prevalence of insulin resistance and its relationship with cardiovascular disease risk factors among Thai adults over 35 years old","volume":"89","author":"Do","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2025092408413438700_CS-2025-7571C10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021041","article-title":"The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning","volume":"6","author":"Qu","year":"2011","journal-title":"PLoS ONE"},{"key":"2025092408413438700_CS-2025-7571C11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"2025092408413438700_CS-2025-7571C12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011295","article-title":"Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults","volume":"8","author":"Raghavan","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"2025092408413438700_CS-2025-7571C13","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"2025092408413438700_CS-2025-7571C14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"The Lancet"},{"key":"2025092408413438700_CS-2025-7571C15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome \u2014 An allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"2025092408413438700_CS-2025-7571C16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp"},{"key":"2025092408413438700_CS-2025-7571C17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"2025092408413438700_CS-2025-7571C18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s001250051333","article-title":"Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation","volume":"43","author":"McEneny","year":"2000","journal-title":"Diabetologia"},{"key":"2025092408413438700_CS-2025-7571C19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.arcmed.2005.01.005","article-title":"Regulation of plasma triglycerides in insulin resistance and diabetes","volume":"36","author":"Ginsberg","year":"2005","journal-title":"Arch. Med. Res."},{"key":"2025092408413438700_CS-2025-7571C20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107334","article-title":"Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man","volume":"52","author":"Brunzell","year":"1973","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C21","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1210\/jc.2003-032056","article-title":"Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity","volume":"89","author":"Cohn","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"key":"2025092408413438700_CS-2025-7571C25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","article-title":"Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association","volume":"7","author":"Bays","year":"2013","journal-title":"J. Clin. Lipidol"},{"key":"2025092408413438700_CS-2025-7571C26","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1046\/j.1523-1755.1999.07133.x","article-title":"Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients","volume":"71","author":"Nishizawa","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"2025092408413438700_CS-2025-7571C27","first-page":"88","article-title":"Apolipoprotein B turnover in dialysis patients: its relationship to pathogenesis of hyperlipidemia","volume":"31","author":"Chan","year":"1989","journal-title":"Clin. Nephrol."},{"key":"2025092408413438700_CS-2025-7571C28","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/ki.1995.239","article-title":"Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment","volume":"47","author":"H\u00f6rkk\u00f6","year":"1995","journal-title":"Kidney Int."},{"key":"2025092408413438700_CS-2025-7571C29","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030470","article-title":"Insulin Resistance Is Associated with an Unfavorable Serum Lipoprotein Lipid Profile in Women with Newly Diagnosed Gestational Diabetes","volume":"13","author":"Huhtala","year":"2023","journal-title":"Biomolecules"},{"key":"2025092408413438700_CS-2025-7571C30","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDL heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J. Lipid Res."},{"key":"2025092408413438700_CS-2025-7571C31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025092408413438700_CS-2025-7571C32","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1152\/ajpendo.00478.2015","article-title":"The glucocorticoid receptor: cause of or cure for obesity?","volume":"310","author":"John","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.00021.2023","article-title":"Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries","volume":"104","author":"Martinez","year":"2024","journal-title":"Physiol. Rev."},{"key":"2025092408413438700_CS-2025-7571C34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020232","article-title":"Overexpression of Glucocorticoid Receptor \u03b2 Enhances Myogenesis and Reduces Catabolic Gene Expression","volume":"17","author":"Hinds","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"2025092408413438700_CS-2025-7571C35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108363","article-title":"Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies","volume":"301","author":"Pauss","year":"2025","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tem.2021.08.003","article-title":"FKBP51 and the molecular chaperoning of metabolism","volume":"32","author":"Smedlund","year":"2021","journal-title":"Trends Endocrinol. Metab"},{"key":"2025092408413438700_CS-2025-7571C37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2008.11.006","article-title":"Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity","volume":"113","author":"Wolf","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2025092408413438700_CS-2025-7571C38","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/en.2009-1158","article-title":"Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice","volume":"151","author":"Warrier","year":"2010","journal-title":"Endocrinology"},{"key":"2025092408413438700_CS-2025-7571C39","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/en.2015-1996","article-title":"FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPAR\u03b3 Agonist Rosiglitazone","volume":"157","author":"Stechschulte","year":"2016","journal-title":"Endocrinology"},{"key":"2025092408413438700_CS-2025-7571C40","doi-asserted-by":"crossref","first-page":"106840","DOI":"10.1016\/j.prostaglandins.2024.106840","article-title":"Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways","volume":"173","author":"Martinez","year":"2024","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2025092408413438700_CS-2025-7571C41","doi-asserted-by":"crossref","first-page":"25776","DOI":"10.1074\/jbc.M116.752311","article-title":"Glucocorticoid Receptor \u03b2 Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) \u03b1","volume":"291","author":"Marino","year":"2016","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C42","doi-asserted-by":"crossref","first-page":"27313","DOI":"10.18632\/oncotarget.8430","article-title":"Glucocorticoid receptor beta increases migration of human bladder cancer cells","volume":"7","author":"McBeth","year":"2016","journal-title":"Oncotarget"},{"key":"2025092408413438700_CS-2025-7571C43","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/384860","article-title":"Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer","volume":"2015","author":"McBeth","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"2025092408413438700_CS-2025-7571C44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/antiox9090889","article-title":"Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1","volume":"9","author":"Hinds","journal-title":"Antioxidants (Basel)."},{"key":"2025092408413438700_CS-2025-7571C45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/antiox11020179","article-title":"Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin","volume":"11","author":"Thomas","journal-title":"Antioxidants (Basel)."},{"key":"2025092408413438700_CS-2025-7571C46","article-title":"Cutting edge concepts: Does bilirubin enhance exercise performance?","volume":"4","author":"Flack","year":"2022","journal-title":"Front. Sports Act. Living"},{"key":"2025092408413438700_CS-2025-7571C47","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1074\/jbc.M110.157875","article-title":"Peroxisome Proliferator-activated Receptor \u03b1 Is Responsible for the Up-regulation of Hepatic Glucose-6-phosphatase Gene Expression in Fasting and db\/db Mice","volume":"286","author":"Im","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"2025092408413438700_CS-2025-7571C48","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1210\/en.2009-0119","article-title":"Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver","volume":"150","author":"Hotta","year":"2009","journal-title":"Endocrinology"},{"key":"2025092408413438700_CS-2025-7571C49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J. Hepatol"},{"key":"2025092408413438700_CS-2025-7571C50","doi-asserted-by":"crossref","first-page":"R733","DOI":"10.1152\/ajpregu.00153.2019","article-title":"Loss of hepatic PPAR\u03b1 promotes inflammation and serum hyperlipidemia in diet-induced obesity","volume":"317","author":"Stec","year":"2019","journal-title":"American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"},{"key":"2025092408413438700_CS-2025-7571C51","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1152\/ajpregu.00057.2023","article-title":"Loss of hepatic PPAR\u03b1 in mice causes hypertension and cardiovascular disease","volume":"325","author":"Badmus","year":"2023","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2025092408413438700_CS-2025-7571C52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/molecules26102975","article-title":"Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha)","volume":"26","author":"Gordon","year":"2021","journal-title":"Molecules"},{"key":"2025092408413438700_CS-2025-7571C53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153427","article-title":"Bilirubin Binding to PPAR\u03b1 Inhibits Lipid Accumulation","volume":"11","author":"Stec","year":"2016","journal-title":"PLoS ONE"},{"key":"2025092408413438700_CS-2025-7571C54","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","article-title":"Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor \u03b1","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1152\/physiolgenomics.00028.2019","article-title":"RNA sequencing in human HepG2 hepatocytes reveals PPAR-\u03b1 mediates transcriptome responsiveness of bilirubin","volume":"51","author":"Gordon","year":"2019","journal-title":"Physiol. Genomics"},{"key":"2025092408413438700_CS-2025-7571C56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594574","article-title":"Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma \u03b2-Hydroxybutyrate","volume":"11","author":"Hinds","year":"2020","journal-title":"Front. Pharmacol."},{"key":"2025092408413438700_CS-2025-7571C57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3350\/cmh.2012.18.4.357","article-title":"Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Jang","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"key":"2025092408413438700_CS-2025-7571C58","doi-asserted-by":"crossref","first-page":"156081","DOI":"10.1016\/j.metabol.2024.156081","article-title":"Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome","volume":"163","author":"Kipp","year":"2025","journal-title":"Metab. Clin. Exp"},{"key":"2025092408413438700_CS-2025-7571C59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.15403\/jgld-4732","article-title":"Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults","volume":"32","author":"Moss","year":"2023","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"2025092408413438700_CS-2025-7571C60","doi-asserted-by":"crossref","first-page":"G668","DOI":"10.1152\/ajpgi.00026.2018","article-title":"Biliverdin reductase and bilirubin in hepatic disease","volume":"314","author":"Weaver","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2025092408413438700_CS-2025-7571C61","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","article-title":"Bilirubin as a metabolic hormone: the physiological relevance of low levels","volume":"320","author":"Creeden","year":"2021","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"2025092408413438700_CS-2025-7571C62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/metabo13020215","article-title":"Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content","volume":"13","author":"Kipp","year":"2023","journal-title":"Metabolites"},{"key":"2025092408413438700_CS-2025-7571C63","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C64","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res."},{"key":"2025092408413438700_CS-2025-7571C65","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/db21-0363","article-title":"Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice","volume":"71","author":"Sun","year":"2021","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C67","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/a-0879-2968","article-title":"Circulating FGF21 levels in human health and metabolic disease","volume":"128","author":"Keuper","year":"2020","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2025092408413438700_CS-2025-7571C68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"2025092408413438700_CS-2025-7571C69","doi-asserted-by":"crossref","first-page":"962561","DOI":"10.3389\/fcvm.2022.962561","article-title":"Multi-organ FGF21-FGFR1 signaling in metabolic health and disease","volume":"9","author":"Kaur","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"2025092408413438700_CS-2025-7571C70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab."},{"key":"2025092408413438700_CS-2025-7571C71","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2007.05.010","article-title":"FGF21: a missing link in the biology of fasting","volume":"5","author":"Reitman","year":"2007","journal-title":"Cell Metab."},{"key":"2025092408413438700_CS-2025-7571C72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1\u03b1 and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev."},{"key":"2025092408413438700_CS-2025-7571C73","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jhep.2024.04.034","article-title":"FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond","volume":"81","author":"Harrison","year":"2024","journal-title":"J. Hepatol."},{"key":"2025092408413438700_CS-2025-7571C74","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbalip.2018.10.008","article-title":"Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)","volume":"1864","author":"Schreiber","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"2025092408413438700_CS-2025-7571C75","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C76","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"2025092408413438700_CS-2025-7571C77","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1210\/jc.2011-0690","article-title":"Hepatic VLDL Overproduction: Is Hyperinsulinemia or Insulin Resistance the Culprit?","volume":"96","author":"Gill","year":"2011","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"2025092408413438700_CS-2025-7571C78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/bj2490037","article-title":"Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin","volume":"249","author":"Bartlett","year":"1988","journal-title":"Biochem. J."},{"key":"2025092408413438700_CS-2025-7571C79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"2025092408413438700_CS-2025-7571C80","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14358","article-title":"Model-based data analysis of individual human postprandial plasma bile acid responses indicates a major role for the gallbladder and intestine","volume":"8","author":"Meessen","year":"2020","journal-title":"Physiol. Rep."},{"key":"2025092408413438700_CS-2025-7571C81","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid Res."},{"key":"2025092408413438700_CS-2025-7571C82","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"2025092408413438700_CS-2025-7571C83","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"2025092408413438700_CS-2025-7571C84","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"key":"2025092408413438700_CS-2025-7571C85","doi-asserted-by":"crossref","first-page":"111618","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol"},{"key":"2025092408413438700_CS-2025-7571C86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2015.01.001","article-title":"Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids","volume":"5","author":"Ferrebee","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"2025092408413438700_CS-2025-7571C87","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C88","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","article-title":"Bile acids are nutrient signaling hormones","volume":"86","author":"Zhou","year":"2014","journal-title":"Steroids"},{"key":"2025092408413438700_CS-2025-7571C89","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"2025092408413438700_CS-2025-7571C90","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"2025092408413438700_CS-2025-7571C91","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"2025092408413438700_CS-2025-7571C92","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1074\/jbc.M209525200","article-title":"The farnesoid X-receptor is an essential regulator of cholesterol homeostasis","volume":"278","author":"Lambert","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C93","article-title":"The effect and safety of obeticholic acid for patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials","volume":"103","author":"Zhao","year":"2024","journal-title":"Medicine (Abingdon)."},{"key":"2025092408413438700_CS-2025-7571C94","doi-asserted-by":"crossref","first-page":"116658","DOI":"10.1016\/j.biopha.2024.116658","article-title":"A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development","volume":"175","author":"Tang","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2025092408413438700_CS-2025-7571C95","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1971.03190100033006","article-title":"Hyperbilirubinemia of fasting","volume":"217","author":"Barrett","year":"1971","journal-title":"JAMA"},{"key":"2025092408413438700_CS-2025-7571C96","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jclinpath-2013-202155","article-title":"Fasting increases serum bilirubin levels in clinically normal, healthy males but not females: a retrospective study from phase I clinical trial participants","volume":"67","author":"Griffin","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"2025092408413438700_CS-2025-7571C97","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2125.1995.tb04424.x","article-title":"The effect of fasting on total serum bilirubin concentrations","volume":"39","author":"Meyer","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2025092408413438700_CS-2025-7571C98","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0016-5085(19)33498-5","article-title":"Studies on the Mechanism of Fasting Hyperbilirubinemia","volume":"61","author":"Bloomer","year":"1971","journal-title":"Gastroenterology"},{"key":"2025092408413438700_CS-2025-7571C99","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.18632\/oncotarget.12277","article-title":"Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?","volume":"8","author":"Sundararaghavan","year":"2017","journal-title":"Oncotarget"},{"key":"2025092408413438700_CS-2025-7571C100","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jhep.2021.06.010","article-title":"Bilirubin: The yellow hormone?","volume":"75","author":"V\u00edtek","year":"2021","journal-title":"J. Hepatol."},{"key":"2025092408413438700_CS-2025-7571C101","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020252","article-title":"Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease","volume":"13","author":"Bates","year":"2023","journal-title":"Biomolecules"},{"key":"2025092408413438700_CS-2025-7571C102","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.trre.2018.06.003","article-title":"Bilirubin, a new therapeutic for kidney transplant?","volume":"32","author":"Sundararaghavan","year":"2018","journal-title":"Transplant. Rev. (Orlando)"},{"key":"2025092408413438700_CS-2025-7571C103","doi-asserted-by":"crossref","first-page":"114592","DOI":"10.1016\/j.bcp.2021.114592","article-title":"UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder","volume":"190","author":"Liu","year":"2021","journal-title":"Biochem. Pharmacol"},{"key":"2025092408413438700_CS-2025-7571C104","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2014.12.042","article-title":"Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert\u2019s syndrome?","volume":"239","author":"Kundur","year":"2015","journal-title":"Atherosclerosis"},{"key":"2025092408413438700_CS-2025-7571C105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41564-023-01549-x","article-title":"BilR is a gut microbial enzyme that reduces bilirubin to urobilinogen","volume":"9","author":"Hall","year":"2024","journal-title":"Nat. Microbiol."},{"key":"2025092408413438700_CS-2025-7571C106","article-title":"and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance. Antioxidants (Basel). 2023","author":"Kipp"},{"key":"2025092408413438700_CS-2025-7571C107","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020302","article-title":"Urobilin Derived from Bilirubin Bioconversion Binds Albumin and May Interfere with Bilirubin Interacting with Albumin: Implications for Disease Pathology","volume":"13","author":"Williams","year":"2025","journal-title":"Biomedicines"},{"key":"2025092408413438700_CS-2025-7571C108","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103462","article-title":"Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV","volume":"13","author":"De Almeida","year":"2021","journal-title":"Nutrients"},{"key":"2025092408413438700_CS-2025-7571C109","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-021-02039-2","article-title":"Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case-control study","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"2025092408413438700_CS-2025-7571C110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054567","article-title":"Dietary fatty acids and inflammation: focus on the n-6 series","volume":"24","author":"Poli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2025092408413438700_CS-2025-7571C111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136304","article-title":"The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity","volume":"10","author":"Yasui","year":"2015","journal-title":"PLoS ONE"},{"key":"2025092408413438700_CS-2025-7571C112","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1073\/pnas.0334211100","article-title":"Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion","volume":"100","author":"Bagga","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025092408413438700_CS-2025-7571C113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107658","article-title":"Reduced dietary omega-6 to omega-3 fatty acid ratio and 12\/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis","volume":"9","author":"Lazic","year":"2014","journal-title":"PLoS ONE"},{"key":"2025092408413438700_CS-2025-7571C114","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.clnu.2020.01.003","article-title":"Associations between omega-6 polyunsaturated fatty acids, hyperinsulinemia and incident diabetes by race\/ethnicity: The Multi-Ethnic Study of Atherosclerosis","volume":"39","author":"Weir","year":"2020","journal-title":"Clin. Nutr"},{"key":"2025092408413438700_CS-2025-7571C115","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1007\/s00394-022-02934-8","article-title":"Prospective dietary polyunsaturated fatty acid intake is associated with trajectories of fatty liver disease: an 8 year follow-up study from adolescence to young adulthood","volume":"61","author":"Wan","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"2025092408413438700_CS-2025-7571C116","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1210\/jc.2019-00160","article-title":"Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial","volume":"104","author":"Rosqvist","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C117","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"key":"2025092408413438700_CS-2025-7571C118","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1152\/ajpendo.00095.2006","article-title":"Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance","volume":"291","author":"Turpin","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C119","doi-asserted-by":"crossref","first-page":"H38","DOI":"10.1152\/ajpheart.01295.2005","article-title":"Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin","volume":"291","author":"Okere","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2025092408413438700_CS-2025-7571C120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"2025092408413438700_CS-2025-7571C121","article-title":"Lipid metabolism in MASLD and MASH: From mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep."},{"key":"2025092408413438700_CS-2025-7571C122","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20060499","article-title":"Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs","volume":"400","author":"Dif","year":"2006","journal-title":"Biochem. J."},{"key":"2025092408413438700_CS-2025-7571C123","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C124","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab"},{"key":"2025092408413438700_CS-2025-7571C125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003102","article-title":"Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies","volume":"17","author":"Imamura","year":"2020","journal-title":"PLoS Med."},{"key":"2025092408413438700_CS-2025-7571C126","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6889533","article-title":"The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD","volume":"2021","author":"Hong","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2025092408413438700_CS-2025-7571C127","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","journal-title":"Antioxidants (Basel)."},{"key":"2025092408413438700_CS-2025-7571C128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radical Biology and Medicine"},{"key":"2025092408413438700_CS-2025-7571C129","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2008.08.068","article-title":"Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells","volume":"375","author":"Sekiya","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025092408413438700_CS-2025-7571C130","doi-asserted-by":"crossref","first-page":"121042","DOI":"10.1016\/j.lfs.2022.121042","article-title":"Reactive oxygen species induce HNF-4\u03b1 expression via the ASK1-CREB pathway, promoting ChREBP expression and lipogenesis in hepatocytes","volume":"310","author":"Seo","year":"2022","journal-title":"Life Sci. (1962)"},{"key":"2025092408413438700_CS-2025-7571C131","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/519153","article-title":"An Intimate Relationship between ROS and Insulin Signalling: Implications for Antioxidant Treatment of Fatty Liver Disease","volume":"2014","author":"Besse-Patin","year":"2014","journal-title":"Int. J. Cell Biol."},{"key":"2025092408413438700_CS-2025-7571C132","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/453892","article-title":"Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis","volume":"2010","author":"Kaneto","year":"2010","journal-title":"Mediators Inflamm."},{"key":"2025092408413438700_CS-2025-7571C133","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/CS20242825","article-title":"Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: a focus on diabetes and therapeutics","volume":"139","author":"Lee","year":"2025","journal-title":"Clin. Sci. (Lond)"},{"key":"2025092408413438700_CS-2025-7571C134","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/HYPERTENSIONAHA.118.11130","article-title":"Bilirubin, a Cardiometabolic Signaling Molecule","volume":"72","author":"Hinds","year":"2018","journal-title":"Hypertension"},{"key":"2025092408413438700_CS-2025-7571C135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tem.2018.01.002","article-title":"Bilirubin in the Liver-Gut Signaling Axis","volume":"29","author":"Hamoud","year":"2018","journal-title":"Trends Endocrinol. Metab"},{"key":"2025092408413438700_CS-2025-7571C136","first-page":"35","article-title":"A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity","volume":"5","author":"Adeosun","year":"2018","journal-title":"React. Oxyg. Species (Apex)."},{"key":"2025092408413438700_CS-2025-7571C137","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102152","article-title":"Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance","volume":"47","author":"Chen","year":"2021","journal-title":"Redox Biol."},{"key":"2025092408413438700_CS-2025-7571C138","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tem.2015.02.001","article-title":"Biliverdin reductase isozymes in metabolism","volume":"26","author":"O\u2019Brien","year":"2015","journal-title":"Trends Endocrinol. Metab"},{"key":"2025092408413438700_CS-2025-7571C139","doi-asserted-by":"crossref","first-page":"108072","DOI":"10.1016\/j.abb.2019.108072","article-title":"CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation","volume":"672","author":"Gordon","year":"2019","journal-title":"Arch. Biochem. Biophys"},{"key":"2025092408413438700_CS-2025-7571C140","doi-asserted-by":"crossref","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","article-title":"Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3\u03b2 Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) \u03b1","volume":"291","author":"Hinds","year":"2016","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C141","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030387","article-title":"Knockout in Adipocytes Induces Hypertrophy and Reduces Mitochondria in White Fat of Obese Mice","volume":"10","author":"Stec","year":"2020","journal-title":"Biomolecules"},{"key":"2025092408413438700_CS-2025-7571C142","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00396.2016","article-title":"Mice with hyperbilirubinemia due to Gilbert\u2019s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPAR\u03b1","volume":"312","author":"Hinds","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C143","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1043-2760(02)00608-2","article-title":"Regulation of insulin action by CEACAM1","volume":"13","author":"Najjar","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C144","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ng840","article-title":"CEACAM1 regulates insulin clearance in liver","volume":"30","author":"Poy","year":"2002","journal-title":"Nat. Genet."},{"key":"2025092408413438700_CS-2025-7571C145","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1083\/jcb.201802095","article-title":"The cell biology of systemic insulin function","volume":"217","author":"Tokarz","year":"2018","journal-title":"J. Cell Biol."},{"key":"2025092408413438700_CS-2025-7571C146","doi-asserted-by":"crossref","first-page":"154735","DOI":"10.1016\/j.metabol.2021.154735","article-title":"Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits","volume":"118","author":"Borges","year":"2021","journal-title":"Metab. Clin. Exp."},{"key":"2025092408413438700_CS-2025-7571C147","first-page":"198","article-title":"Hepatic Insulin Clearance: Mechanism and Physiology","volume":"34","author":"Najjar","year":"2019","journal-title":"Physiology (Bethesda)."},{"key":"2025092408413438700_CS-2025-7571C148","doi-asserted-by":"crossref","first-page":"154352","DOI":"10.1016\/j.metabol.2020.154352","article-title":"Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice","volume":"113","author":"Merino","year":"2020","journal-title":"Metab. Clin. Exp"},{"key":"2025092408413438700_CS-2025-7571C149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2018.08.001","article-title":"Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice","volume":"88","author":"Villa-P\u00e9rez","year":"2018","journal-title":"Metab. Clin. Exp."},{"key":"2025092408413438700_CS-2025-7571C150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/biomedicines9010086","article-title":"Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme","volume":"9","author":"Gonz\u00e1lez-Casimiro","year":"2021","journal-title":"Biomedicines"},{"key":"2025092408413438700_CS-2025-7571C151","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2005.06.001","article-title":"Insulin acutely decreases hepatic fatty acid synthase activity","volume":"2","author":"Najjar","year":"2005","journal-title":"Cell Metab."},{"key":"2025092408413438700_CS-2025-7571C152","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081899","article-title":"Regulation of insulin clearance by non-esterified fatty acids","volume":"10","author":"Najjar","year":"2022","journal-title":"Biomedicines"},{"key":"2025092408413438700_CS-2025-7571C153","first-page":"69","article-title":"Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis","volume":"2010","author":"Ghosh","year":"2010","journal-title":"Hepat. Med."},{"key":"2025092408413438700_CS-2025-7571C154","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102010","article-title":"Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation","volume":"88","author":"Muturi","year":"2024","journal-title":"Mol. Metab."},{"key":"2025092408413438700_CS-2025-7571C155","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2006.08.026","article-title":"SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms","volume":"25","author":"Nagaishi","year":"2006","journal-title":"Immunity"},{"key":"2025092408413438700_CS-2025-7571C156","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.2337\/db14-1772","article-title":"Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance","volume":"64","author":"Al-Share","year":"2015","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C157","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1194\/jlr.M072066","article-title":"Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis","volume":"57","author":"Russo","year":"2016","journal-title":"J. Lipid Res"},{"key":"2025092408413438700_CS-2025-7571C158","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-6-40","article-title":"The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes","volume":"6","author":"Lee","year":"2011","journal-title":"Diagn. Pathol."},{"key":"2025092408413438700_CS-2025-7571C159","doi-asserted-by":"crossref","first-page":"21873","DOI":"10.3390\/ijms141121873","article-title":"Hepatic adverse effects of fructose consumption independent of overweight\/obesity","volume":"14","author":"Schultz","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"2025092408413438700_CS-2025-7571C160","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.7150\/ijbs.97309","article-title":"High dietary Fructose Drives Metabolic Dysfunction-Associated Steatotic Liver Disease via Activating ubiquitin-specific peptidase 2\/11\u03b2-hydroxysteroid dehydrogenase type 1 Pathway in Mice","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"2025092408413438700_CS-2025-7571C161","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI96702","article-title":"Fructose metabolism and metabolic disease","volume":"128","author":"Hannou","year":"2018","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C162","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.184396","article-title":"Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism","volume":"9","author":"Park","year":"2024","journal-title":"JCI Insight"},{"key":"2025092408413438700_CS-2025-7571C163","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/bies.200900167","article-title":"The biological significance of substrate inhibition: a mechanism with diverse functions","volume":"32","author":"Reed","year":"2010","journal-title":"Bioessays"},{"key":"2025092408413438700_CS-2025-7571C164","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cmet.2012.05.002","article-title":"Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression","volume":"15","author":"Haas","year":"2012","journal-title":"Cell Metab."},{"key":"2025092408413438700_CS-2025-7571C165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047948","article-title":"Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver","volume":"7","author":"Lanaspa","year":"2012","journal-title":"PLoS ONE"},{"key":"2025092408413438700_CS-2025-7571C166","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.medj.2021.04.007","article-title":"Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial","volume":"2","author":"Kazierad","year":"2021","journal-title":"Med"},{"key":"2025092408413438700_CS-2025-7571C167","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbadis.2016.11.029","article-title":"The transcription factor carbohydrate-response element-binding protein (ChREBP): A possible link between metabolic disease and cancer","volume":"1863","author":"Iizuka","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"2025092408413438700_CS-2025-7571C168","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-019-1024-5","article-title":"The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria","volume":"18","author":"Garc\u00eda-Berumen","year":"2019","journal-title":"Lipids Health Dis."},{"key":"2025092408413438700_CS-2025-7571C169","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cmet.2019.09.003","article-title":"Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins","volume":"30","author":"Softic","year":"2019","journal-title":"Cell Metab"},{"key":"2025092408413438700_CS-2025-7571C170","doi-asserted-by":"crossref","first-page":"E1180","DOI":"10.1152\/ajpendo.00471.2001","article-title":"Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha","volume":"282","author":"Nagai","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C171","doi-asserted-by":"crossref","first-page":"108391","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets","volume":"245","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther"},{"key":"2025092408413438700_CS-2025-7571C172","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C173","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPAR\u03b3 in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Mor\u00e1n-Salvador","year":"2011","journal-title":"FASEB J."},{"key":"2025092408413438700_CS-2025-7571C174","doi-asserted-by":"crossref","first-page":"115165","DOI":"10.1016\/j.celrep.2024.115165","article-title":"The adiponectin-PPAR\u03b3 axis in hepatic stellate cells regulates liver fibrosis","volume":"44","author":"Zhao","year":"2025","journal-title":"Cell Rep"},{"key":"2025092408413438700_CS-2025-7571C175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metab"},{"key":"2025092408413438700_CS-2025-7571C176","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: the forgotten diabetes medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"2025092408413438700_CS-2025-7571C177","article-title":"The role of thiazolidinediones in the amelioration of nonalcoholic fatty liver disease: a systematic review","volume":"14","author":"Ndakotsu","year":"2022","journal-title":"Cureus"},{"key":"2025092408413438700_CS-2025-7571C178","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4810672","article-title":"Deciphering the Roles of Thiazolidinediones and PPAR\u03b3 in Bladder Cancer","volume":"2017","author":"Chiu","year":"2017","journal-title":"PPAR Res."},{"key":"2025092408413438700_CS-2025-7571C179","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3645","article-title":"The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study","volume":"344","author":"Azoulay","year":"2012","journal-title":"BMJ"},{"key":"2025092408413438700_CS-2025-7571C180","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500718R","article-title":"Fibrogenic gene signature as early prediction for the efficacy of pharmacological interventions for MASH-associated fibrosis","volume":"39","author":"Inia","year":"2025","journal-title":"FASEB J."},{"key":"2025092408413438700_CS-2025-7571C181","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/db10-0801","article-title":"Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C182","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmet.2011.04.013","article-title":"Protection from obesity and diabetes by blockade of TGF-\u03b2\/Smad3 signaling","volume":"14","author":"Yadav","year":"2011","journal-title":"Cell Metab."},{"key":"2025092408413438700_CS-2025-7571C183","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hep.32467","article-title":"Hepatic kinome atlas: an in-depth identification of kinase pathways in liver fibrosis of humans and rodents","volume":"76","author":"Creeden","year":"2022","journal-title":"Hepatology"},{"key":"2025092408413438700_CS-2025-7571C184","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2337\/db23-0180","article-title":"Reciprocal regulation of hepatic TGF-\u03b21 and foxo1 controls gluconeogenesis and energy expenditure","volume":"72","author":"Pan","year":"2023","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jnutbio.2016.07.017","article-title":"Characterization of TGF-\u03b2 expression and signaling profile in the adipose tissue of rats fed with high-fat and energy-restricted diets","volume":"38","author":"Sousa-Pinto","year":"2016","journal-title":"J. Nutr. Biochem"},{"key":"2025092408413438700_CS-2025-7571C186","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402169R","article-title":"Insulin receptor responsiveness governs TGF\u03b2-induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis","volume":"39","author":"Lee","year":"2025","journal-title":"FASEB J."},{"key":"2025092408413438700_CS-2025-7571C187","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105691","article-title":"FOXS1 is increased in liver fibrosis and regulates TGF\u03b2 responsiveness and proliferation pathways in human hepatic stellate cells","volume":"300","author":"Bates","year":"2024","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C188","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative hyaluronic acid-bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"key":"2025092408413438700_CS-2025-7571C189","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jceh.2017.11.001","article-title":"Nutrition and muscle in cirrhosis","volume":"7","author":"Anand","year":"2017","journal-title":"J. Clin. Exp. Hepatol."},{"key":"2025092408413438700_CS-2025-7571C190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/embo-reports\/kve071","article-title":"Mechanisms of nutritional and hormonal regulation of lipogenesis","volume":"2","author":"Kersten","year":"2001","journal-title":"EMBO Rep."},{"key":"2025092408413438700_CS-2025-7571C191","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4331\/wjbc.v11.i3.76","article-title":"Current understanding of glucose transporter 4 expression and functional mechanisms","volume":"11","author":"Wang","year":"2020","journal-title":"World J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C192","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr. Opin. Cell Biol"},{"key":"2025092408413438700_CS-2025-7571C193","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101383","article-title":"Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues","volume":"10","author":"Song","year":"2018","journal-title":"Nutrients"},{"key":"2025092408413438700_CS-2025-7571C194","doi-asserted-by":"crossref","first-page":"E653","DOI":"10.1152\/ajpendo.00620.2020","article-title":"100th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism","volume":"320","author":"Carpentier","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C195","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/db16-1167","article-title":"Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the san antonio metabolism study","volume":"66","author":"Gastaldelli","year":"2017","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C196","article-title":"Visceral fat and diabetes: associations with liver fibrosis in metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Kumar","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"2025092408413438700_CS-2025-7571C197","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.13569","article-title":"Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018","volume":"16","author":"Mai","year":"2024","journal-title":"J. Diabetes"},{"key":"2025092408413438700_CS-2025-7571C198","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/joim.12540","article-title":"Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids","volume":"280","author":"Smith","year":"2016","journal-title":"J. Intern. Med."},{"key":"2025092408413438700_CS-2025-7571C199","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI96139","article-title":"Insulin resistance causes inflammation in adipose tissue","volume":"128","author":"Shimobayashi","year":"2018","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C200","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C201","article-title":"Adipokines Mediate Inflammation and Insulin Resistance","volume":"4","author":"Kwon","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2025092408413438700_CS-2025-7571C202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MED.0b013e3283514e13","article-title":"What causes the insulin resistance underlying obesity?","volume":"19","author":"Hardy","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes. Obes."},{"key":"2025092408413438700_CS-2025-7571C203","doi-asserted-by":"crossref","first-page":"35279","DOI":"10.1074\/jbc.M706762200","article-title":"A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways","volume":"282","author":"Nguyen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C204","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C205","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"2025092408413438700_CS-2025-7571C206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev-nutr-072610-145209","article-title":"The implication of brown adipose tissue for humans","volume":"31","author":"Ravussin","year":"2011","journal-title":"Annu. Rev. Nutr."},{"key":"2025092408413438700_CS-2025-7571C207","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2012.09.010","article-title":"Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria","volume":"151","author":"Fedorenko","year":"2012","journal-title":"Cell"},{"key":"2025092408413438700_CS-2025-7571C208","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nature08262","article-title":"Initiation of myoblast to brown fat switch by a PRDM16-C\/EBP-beta transcriptional complex","volume":"460","author":"Kajimura","year":"2009","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C209","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2025092408413438700_CS-2025-7571C210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3803\/EnM.2023.1659","article-title":"Brown adipose tissue: activation and metabolism in humans","volume":"38","author":"Hachemi","year":"2023","journal-title":"Endocrinol. Metab. (Seoul)."},{"key":"2025092408413438700_CS-2025-7571C211","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041530","article-title":"Brown adipose tissue and its role in insulin and glucose homeostasis","volume":"22","author":"Maliszewska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2025092408413438700_CS-2025-7571C212","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejphar.2019.02.044","article-title":"Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice","volume":"854","author":"Shankar","year":"2019","journal-title":"Eur. J. Pharmacol"},{"key":"2025092408413438700_CS-2025-7571C213","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm.3891","article-title":"Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus","volume":"21","author":"Hanssen","year":"2015","journal-title":"Nat. Med."},{"key":"2025092408413438700_CS-2025-7571C214","doi-asserted-by":"crossref","first-page":"102116","DOI":"10.1016\/j.jksus.2022.102116","article-title":"PPARG expression patterns and correlations in obesity","volume":"34","author":"Darwish","year":"2022","journal-title":"Journal of King Saud University - Science"},{"key":"2025092408413438700_CS-2025-7571C215","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI119424","article-title":"Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids","volume":"99","author":"Vidal-Puig","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C216","first-page":"2619","article-title":"Physical activity and exercise promote peroxisome proliferator-activated receptor gamma expression in adipose tissues of obese adults","volume":"51","author":"Zarkesh","year":"2022","journal-title":"Iran. J. Public Health"},{"key":"2025092408413438700_CS-2025-7571C217","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11605-021-05216-6","article-title":"PPAR-\u03b3 gene expression in human adipose tissue is associated with weight loss after sleeve gastrectomy","volume":"26","author":"Torres","year":"2022","journal-title":"J. Gastrointest. Surg."},{"key":"2025092408413438700_CS-2025-7571C218","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","article-title":"PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance","volume":"4","author":"Kubota","year":"1999","journal-title":"Mol. Cell"},{"key":"2025092408413438700_CS-2025-7571C219","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1073\/pnas.2536828100","article-title":"Adipose-specific peroxisome proliferator-activated receptor \u03b3 knockout causes insulin resistance in fat and liver but not in muscle","volume":"100","author":"He","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2025092408413438700_CS-2025-7571C220","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.0306743102","article-title":"Deletion of PPAR\u03b3 in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance","volume":"102","author":"Jones","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2025092408413438700_CS-2025-7571C221","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/sj.bjp.0707452","article-title":"Thiazolidinediones: effects on insulin resistance and the cardiovascular system","volume":"153","author":"Quinn","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"2025092408413438700_CS-2025-7571C222","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/oby.2009.380","article-title":"Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue","volume":"18","author":"McLaughlin","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"2025092408413438700_CS-2025-7571C223","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0026-0495(03)00055-6","article-title":"Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes","volume":"52","author":"Boden","year":"2003","journal-title":"Metab. Clin. Exp."},{"key":"2025092408413438700_CS-2025-7571C224","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI11245","article-title":"Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones","volume":"106","author":"Chao","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","article-title":"Peroxisome proliferator-activated receptors in inflammation control","volume":"169","author":"Delerive","year":"2001","journal-title":"J. Endocrinol."},{"key":"2025092408413438700_CS-2025-7571C226","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C227","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C228","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1158\/0008-5472.CAN-20-0652","article-title":"A Transcriptional regulatory loop of master regulator transcription factors, PPARG, and fatty acid synthesis promotes esophageal adenocarcinoma","volume":"81","author":"Ma","year":"2021","journal-title":"Cancer Res."},{"key":"2025092408413438700_CS-2025-7571C229","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C230","doi-asserted-by":"crossref","first-page":"28169","DOI":"10.1074\/jbc.M111.332106","article-title":"GQ-16, a novel peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) ligand, promotes insulin sensitization without weight gain","volume":"287","author":"Amato","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C231","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature10383","article-title":"Antidiabetic actions of a non-agonist PPAR\u03b3 ligand blocking Cdk5-mediated phosphorylation","volume":"477","author":"Choi","year":"2011","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C232","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1126\/science.274.5295.2100","article-title":"Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma","volume":"274","author":"Hu","year":"1996","journal-title":"Science"},{"key":"2025092408413438700_CS-2025-7571C233","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1210\/me.2005-0222","article-title":"Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis","volume":"20","author":"Iankova","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"2025092408413438700_CS-2025-7571C234","doi-asserted-by":"crossref","first-page":"42911","DOI":"10.1074\/jbc.M111.311662","article-title":"Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3)","volume":"286","author":"Hinds","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2017.10.023","article-title":"Genetic inhibition of PPAR\u03b3 S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis","volume":"107","author":"Ge","year":"2018","journal-title":"Bone"},{"key":"2025092408413438700_CS-2025-7571C236","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010004","article-title":"Adipose-Specific PPAR\u03b1 Knockout Mice Have Increased Lipogenesis by PASK-SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue","volume":"11","author":"Hinds","year":"2021","journal-title":"Cells"},{"key":"2025092408413438700_CS-2025-7571C237","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.2337\/diabetes.54.12.3358","article-title":"Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination","volume":"54","author":"Tsuchida","year":"2005","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C238","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1478-3231.2006.01265.x","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver","volume":"26","author":"Harano","year":"2006","journal-title":"Liver Int."},{"key":"2025092408413438700_CS-2025-7571C239","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006676-200304000-00013","article-title":"Bezafibrate, a peroxisome proliferator-activated receptor (PPAR)-alpha activator, prevents pancreatic degeneration in obese and diabetic rats","volume":"26","author":"Jia","year":"2003","journal-title":"Pancreas"},{"key":"2025092408413438700_CS-2025-7571C240","doi-asserted-by":"crossref","first-page":"28662","DOI":"10.1074\/jbc.M403271200","article-title":"THe peroxisome proliferator-activated receptor alpha (pparalpha) agonist ciprofibrate inhibits apolipoprotein b mrna editing in low density lipoprotein receptor-deficient mice: Effects on plasma lipoproteins and the development of atherosclerotic lesions","volume":"279","author":"Fu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C241","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-2275(20)39388-3","article-title":"Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia","volume":"13","author":"Grundy","year":"1972","journal-title":"J. Lipid Res."},{"key":"2025092408413438700_CS-2025-7571C242","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.ATV.0000154140.73570.00","article-title":"Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation","volume":"25","author":"Duez","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025092408413438700_CS-2025-7571C243","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-020-0823-5","article-title":"Pemafibrate, a New Selective PPAR\u03b1 Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases","volume":"22","author":"Yamashita","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"2025092408413438700_CS-2025-7571C244","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metab"},{"key":"2025092408413438700_CS-2025-7571C245","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/dom.12620","article-title":"Aleglitazar, a dual peroxisome proliferator-activated receptor-\u03b1\/\u03b3 agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial","volume":"18","author":"Stirban","year":"2016","journal-title":"Diabetes. Obes. Metab."},{"key":"2025092408413438700_CS-2025-7571C246","doi-asserted-by":"crossref","first-page":"155912","DOI":"10.1016\/j.metabol.2024.155912","article-title":"Deciphering the molecular pathways of saroglitazar: A dual PPAR \u03b1\/\u03b3 agonist for managing metabolic NAFLD","volume":"155","author":"Ezhilarasan","year":"2024","journal-title":"Metab. Clin. Exp."},{"key":"2025092408413438700_CS-2025-7571C247","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.07.046","article-title":"Nox family NADPH oxidases: Molecular mechanisms of activation","volume":"76","author":"Brandes","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"2025092408413438700_CS-2025-7571C248","article-title":"Redox Regulation of Lipid Mobilization in Adipose Tissues","volume":"10","author":"Abou-Rjeileh","year":"2021","journal-title":"Antioxidants (Basel)."},{"key":"2025092408413438700_CS-2025-7571C249","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1515\/hsz-2015-0305","article-title":"The two faces of reactive oxygen species (ROS) in adipocyte function and dysfunction","volume":"397","author":"Castro","year":"2016","journal-title":"Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C250","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/MCB.24.5.1844-1854.2004","article-title":"The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction","volume":"24","author":"Mahadev","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2025092408413438700_CS-2025-7571C251","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/ATVBAHA.108.174219","article-title":"Nox4 acts as a switch between differentiation and proliferation in preadipocytes","volume":"29","author":"Schr\u00f6der","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2025092408413438700_CS-2025-7571C252","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/oby.24113","article-title":"NADPH oxidases in healthy white adipose tissue and in obesity: function, regulation, and clinical implications","volume":"32","author":"Jornayvaz","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"2025092408413438700_CS-2025-7571C253","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database (Oxford)"},{"key":"2025092408413438700_CS-2025-7571C254","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"De Luca","year":"2008","journal-title":"FEBS Lett"},{"key":"2025092408413438700_CS-2025-7571C255","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C256","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1464-5491.2002.00846.x","article-title":"Tumour necrosis factor-alpha plasma levels in elderly patients with Type 2 diabetes mellitus-observations over 2 years","volume":"19","author":"Lechleitner","year":"2002","journal-title":"Diabet. Med."},{"key":"2025092408413438700_CS-2025-7571C257","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/gast.2002.31065","article-title":"Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease","volume":"122","author":"Valenti","year":"2002","journal-title":"Gastroenterology"},{"key":"2025092408413438700_CS-2025-7571C258","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2337\/diabetes.54.10.2939","article-title":"Tumor Necrosis Factor-\u03b1 Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 Phosphorylation","volume":"54","author":"Plomgaard","year":"2005","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C259","article-title":"Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes","volume":"10","author":"Zatterale","year":"2019","journal-title":"Front. Physiol."},{"key":"2025092408413438700_CS-2025-7571C260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1389450043490523","article-title":"Adipose tissue as a regulator of energy balance","volume":"5","author":"Klaus","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"2025092408413438700_CS-2025-7571C261","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/rp.56.1.329","article-title":"The adipocyte as a secretory organ: mechanisms of vesicle transport and secretory pathways","volume":"56","author":"Bradley","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"2025092408413438700_CS-2025-7571C262","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat. Med."},{"key":"2025092408413438700_CS-2025-7571C263","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat. Med."},{"key":"2025092408413438700_CS-2025-7571C264","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025092408413438700_CS-2025-7571C265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11892-003-0065-2","article-title":"Adiponectin: systemic contributor to insulin sensitivity","volume":"3","author":"Pajvani","year":"2003","journal-title":"Curr. Diab. Rep."},{"key":"2025092408413438700_CS-2025-7571C266","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI14120","article-title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30","volume":"108","author":"Combs","year":"2001","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C267","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1399-5448.2003.00017.x","article-title":"Leptin: obesity, diabetes and other peripheral effects - a review","volume":"4","author":"Moran","year":"2003","journal-title":"Pediatr. Diabetes"},{"key":"2025092408413438700_CS-2025-7571C268","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1074\/jbc.272.16.10585","article-title":"Leptin Impairs Metabolic Actions of Insulin in Isolated Rat Adipocytes","volume":"272","author":"M\u00fcller","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"2025092408413438700_CS-2025-7571C269","article-title":"Association of leptin with obesity and insulin resistance","volume":"12","author":"Kumar","year":"2020","journal-title":"Cureus"},{"key":"2025092408413438700_CS-2025-7571C270","doi-asserted-by":"crossref","first-page":"e1402","DOI":"10.1210\/clinem\/dgad653","article-title":"Leptin and insulin sensitivity: endogenous signals of metabolic homeostasis","volume":"109","author":"Dagogo-Jack","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C271","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"2025092408413438700_CS-2025-7571C272","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/cimm.1999.1594","article-title":"Human leptin enhances activation and proliferation of human circulating T lymphocytes","volume":"199","author":"Mart\u00edn-Romero","year":"2000","journal-title":"Cell. Immunol."},{"key":"2025092408413438700_CS-2025-7571C273","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1172\/JCI6762","article-title":"Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob\/ob mice","volume":"104","author":"Howard","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2025092408413438700_CS-2025-7571C274","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","article-title":"Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects","volume":"84","author":"Ozata","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C275","first-page":"783","article-title":"Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes","volume":"86","author":"Gabay","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C276","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/cimm.1999.1490","article-title":"Human leptin stimulates proliferation and activation of human circulating monocytes","volume":"194","author":"Santos-Alvarez","year":"1999","journal-title":"Cell. Immunol."},{"key":"2025092408413438700_CS-2025-7571C277","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.167.8.4593","article-title":"High-dose leptin activates human leukocytes via receptor expression on monocytes","volume":"167","author":"Zarkesh-Esfahani","year":"2001","journal-title":"J. Immunol."},{"key":"2025092408413438700_CS-2025-7571C278","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","article-title":"Adiponectin as an anti-inflammatory factor","volume":"380","author":"Ouchi","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"2025092408413438700_CS-2025-7571C279","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat. Med."},{"key":"2025092408413438700_CS-2025-7571C280","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/diabetes.52.6.1355","article-title":"Involvement of amp-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes","volume":"52","author":"Wu","year":"2003","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C281","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"Jialal","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C282","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415682","article-title":"Opposing Actions of TLR2 and TLR4 in adipocyte differentiation and mature-onset obesity","volume":"23","author":"Cuesta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"2025092408413438700_CS-2025-7571C283","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","article-title":"Discrimination of bacterial lipoproteins by Toll-like receptor 6","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Int. Immunol."},{"key":"2025092408413438700_CS-2025-7571C284","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1096\/fj.09-141929","article-title":"Tlr2 is critical for diet-induced metabolic syndrome in a murine model","volume":"24","author":"Himes","year":"2010","journal-title":"FASEB J."},{"key":"2025092408413438700_CS-2025-7571C285","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/ncomms4878","article-title":"Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance","volume":"5","author":"Jia","year":"2014","journal-title":"Nat. Commun."},{"key":"2025092408413438700_CS-2025-7571C286","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.celrep.2014.03.062","article-title":"Immune cell Toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosis","volume":"7","author":"Vila","year":"2014","journal-title":"Cell Rep"},{"key":"2025092408413438700_CS-2025-7571C287","doi-asserted-by":"crossref","first-page":"24255","DOI":"10.1074\/jbc.M002137200","article-title":"The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes","volume":"275","author":"Lin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2025092408413438700_CS-2025-7571C288","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.shk.0000055237.25446.80","article-title":"Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle","volume":"19","author":"Lang","year":"2003","journal-title":"Shock"},{"key":"2025092408413438700_CS-2025-7571C289","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1189\/jlb.1103543","article-title":"Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system","volume":"75","author":"Netea","year":"2004","journal-title":"J. Leukoc. Biol"},{"key":"2025092408413438700_CS-2025-7571C290","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00125-010-1931-5","article-title":"Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse","volume":"54","author":"Kuo","year":"2011","journal-title":"Diabetologia"},{"key":"2025092408413438700_CS-2025-7571C291","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors - redefining innate immunity","volume":"13","author":"O\u2019Neill","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"2025092408413438700_CS-2025-7571C292","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/en.2017-00024","article-title":"Short-Term Versus Long-Term Effects of Adipocyte Toll-Like Receptor 4 Activation on Insulin Resistance in Male Mice","volume":"158","author":"Tao","year":"2017","journal-title":"Endocrinology"},{"key":"2025092408413438700_CS-2025-7571C293","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmet.2009.09.006","article-title":"Hematopoietic Cell-Specific Deletion of Toll-like Receptor 4 Ameliorates Hepatic and Adipose Tissue Insulin Resistance in High-Fat-Fed Mice","volume":"10","author":"Saberi","year":"2009","journal-title":"Cell Metab"},{"key":"2025092408413438700_CS-2025-7571C294","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.omtn.2022.03.005","article-title":"First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers","volume":"28","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2025092408413438700_CS-2025-7571C295","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","article-title":"The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease","volume":"12","author":"Vachliotis","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"2025092408413438700_CS-2025-7571C296","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2003-030214","article-title":"Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies","volume":"88","author":"Gavrila","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025092408413438700_CS-2025-7571C297","first-page":"2801","article-title":"Adiponectin, a key adipokine in obesity related liver diseases","volume":"17","author":"Buechler","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"2025092408413438700_CS-2025-7571C298","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-024-02176-w","article-title":"Crosstalk between fat tissue and muscle, brain, liver, and heart in obesity: cellular and molecular perspectives","volume":"29","author":"Jia","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"2025092408413438700_CS-2025-7571C299","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.2337\/db05-1322","article-title":"Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha","volume":"55","author":"Yoon","year":"2006","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C300","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","article-title":"Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk","volume":"23","author":"Stern","year":"2016","journal-title":"Cell Metab"},{"key":"2025092408413438700_CS-2025-7571C301","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/db20-1073","article-title":"Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration","volume":"70","author":"Ryu","year":"2021","journal-title":"Diabetes"},{"key":"2025092408413438700_CS-2025-7571C302","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-08-0900","article-title":"Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts","volume":"160","author":"Kotronen","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"2025092408413438700_CS-2025-7571C303","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1007\/s00125-005-1948-3","article-title":"Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat","volume":"48","author":"Stefan","year":"2005","journal-title":"Diabetologia"},{"key":"2025092408413438700_CS-2025-7571C304","article-title":"Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients","volume":"16","author":"Fajki\u0107","year":"2024","journal-title":"Cureus"},{"key":"2025092408413438700_CS-2025-7571C305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s42000-022-00387-6","article-title":"Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study","volume":"21","author":"Mantovani","year":"2022","journal-title":"Hormones (Athens)."},{"key":"2025092408413438700_CS-2025-7571C306","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41366-022-01079-2","article-title":"Mechanisms of reduced leptin-mediated satiety signaling during obesity","volume":"46","author":"Park","year":"2022","journal-title":"Int. J. Obes. (Lond)"},{"key":"2025092408413438700_CS-2025-7571C307","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165887","article-title":"Role of Leptin in Inflammation and Vice Versa","volume":"21","author":"P\u00e9rez-P\u00e9rez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2025092408413438700_CS-2025-7571C308","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10684-1","article-title":"Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis","volume":"10","author":"Hackl","year":"2019","journal-title":"Nat. Commun."},{"key":"2025092408413438700_CS-2025-7571C309","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126420","article-title":"Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans","volume":"25","author":"De la Cruz-Color","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2025092408413438700_CS-2025-7571C310","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070762","article-title":"Role of leptin in non-alcoholic fatty liver disease","volume":"9","author":"Jim\u00e9nez-Cortegana","year":"2021","journal-title":"Biomedicines"},{"key":"2025092408413438700_CS-2025-7571C311","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: Similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J. Diabetes Investig."},{"key":"2025092408413438700_CS-2025-7571C312","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/jn.114.206029","article-title":"Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling","volume":"145","author":"Ronveaux","year":"2015","journal-title":"J. Nutr."},{"key":"2025092408413438700_CS-2025-7571C313","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2025.171416","article-title":"Spexin is a biomarker of the process that regulates leptin sensitivity","volume":"190","author":"Ahmed","year":"2025","journal-title":"Peptides"},{"key":"2025092408413438700_CS-2025-7571C314","article-title":"Control of Brown Adipose Tissue Glucose and Lipid Metabolism by PPAR\u03b3","volume":"2","author":"Festuccia","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2025092408413438700_CS-2025-7571C315","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s001250051477","article-title":"Diabetic neuropathies","volume":"43","author":"Vinik","year":"2000","journal-title":"Diabetologia"},{"key":"2025092408413438700_CS-2025-7571C316","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11030230","article-title":"Differences and similarities in neuropathy in type 1 and 2 diabetes: a systematic review","volume":"11","author":"Sempere-Bigorra","year":"2021","journal-title":"J. Pers. Med."},{"key":"2025092408413438700_CS-2025-7571C317","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221766","article-title":"Neuropathy and neural plasticity in the subcutaneous white adipose depot","volume":"14","author":"Blaszkiewicz","year":"2019","journal-title":"PLoS ONE"},{"key":"2025092408413438700_CS-2025-7571C318","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1113\/JP277994","article-title":"Liver sympathetic denervation reverses obesity-induced hepatic steatosis","volume":"597","author":"Hurr","year":"2019","journal-title":"J. Physiol. (Lond.)"},{"key":"2025092408413438700_CS-2025-7571C319","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cmet.2021.01.012","article-title":"Metabolic stress drives sympathetic neuropathy within the liver","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/doi\/10.1042\/CS20257571\/978413\/cs-2025-7571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/doi\/10.1042\/CS20257571\/978413\/cs-2025-7571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T12:42:25Z","timestamp":1758717745000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/139\/18\/1015\/236565\/The-physiology-of-MASLD-molecular-pathways-between"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":319,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,9,24]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20257571","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9]]}}}